Postnatal inflammatory rat model for cerebral palsy: Too different from humans

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 4, 2006, Pages 1038-1044

  Roberson, Robin ^a   Woodard, Jade E ^a   Toso, Laura ^a   Abebe, Daniel ^a   Poggi, Sarah H ^a,b   Spong, Catherine Y ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Department of Obstetrics and Gynecology   (United States)

Author keywords

Cerebral palsy; Lipopolysaccharide; Periventricular leukomalacia; Rat

Indexed keywords

LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CEREBRAL PALSY; COGNITIVE DEVELOPMENT; CONTROLLED STUDY; EXPOSURE; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOTOR ACTIVITY; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; RAT; ROTAROD TEST; WALKING; WHITE MATTER;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CEREBRAL PALSY; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPOPOLYSACCHARIDES; MYELIN PROTEOLIPID PROTEIN; PREGNANCY; RATS; RATS, INBRED F344; SPECIES SPECIFICITY;

EID: 33748759850     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.06.046     Document Type: Article

References (24)

1. Kuban K.C., and Leviton A. Cerebral palsy. N Engl J Med 330 (1994) 188-195
2. Bell M.J., and Hallenbeck J.M. Effects of intrauterine inflammation on developing rat brain. J Neurosci Res 70 (2002) 570-579
3. Poggi S., Park J., Toso L., Einat H., Roberson R., Dunlap V., et al. No phenotype associated with established lipopolysaccharide model for cerebral palsy. Am J Obstet Gynecol 192 (2004) 727-733
4. Toso L., Poggi S., Park J., Toso L., Einat H., Roberson R., et al. Inflammatory-mediated model of cerebral palsy with developmental sequelae. Am J Obstet Gynecol 193 (2005) 933-941
5. Nelson K., Dambrosia J., Grether J., and Phillips T. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 44 (1998) 665-675
6. Schendel D., Schuchat A., and Thorsen P. Public health issues related to infection and pregnancy and cerebral palsy. Ment Retard Dev Disabil Res Rev 8 (2002) 39-45
7. Yoon B.H., Park C.W., and Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. BJOG 110 (2003) 124-127
8. Wu Y.W., and Colford J.M. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 848 (2000) 1417-1424
9. Russel P. Inflammatory lesions of the human placenta, I: clinical significance of acute chorioamnionitis. Am J Diagn Gynaecol Obstet 1 (1979) 127-137
10. Craig A., Luo N.L., Beardsley D.J., Wingate-Pearse N., Walker D., Hominer A.R., et al. Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 181 (2003) 231-340
11. Debillon T., Gras-Leguen C., Verielle V., Winer N., Caillon J., Roze J.C., et al. Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res 47 (2000) 736-742
12. Dalmau I., Vela J.M., Gonzalez B., and Castellano B. Expression of LFA-1α and ICAM-1 in the developing rat brain: a potential; mechanism for the recruitment of microglial cell precursors. Dev Brain Res 103 (1997) 163-170
13. Pang Y., Cai Z., and Rhodes P.G. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res Dev Brain Res 140 (2003) 205-214
14. Engeland C.G., Nielsem D.V., Kavaliers M., and Ossenkopp K.P. Locomotor activity following lipopolysaccaride treatment in mice: a multivariate assessment if behavioral tolerance. Physiol Behav 72 (2001) 481-491
15. Wu J.Y., Henins K.A., Gressens P., Gozes I., Fridkin M., Brenneman D.E., et al. Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period. Peptides 18 (1991) 1131-1137
16. Crawford J.N. What's wrong with my mouse: behavioral phenotyping of transgenic and knockout mice (2000), Wiley-Liss, New York p. 47-69
17. Buddeberg B.S., Kerschensteiner M., Merkler D., Stadelmann C., and Scwab M.E. Behavioral testing strategies in a localized animal model of multiple sclerosis. J Neuroimmunol 153 (2004) 158-170
18. Zhang J., Chen X., Du J., Chen Q., and Zhu C. Neonatal exposure to intermittent hypoxia enhances mice performance in water maze and 8-arm radial maze tasks. J Neurobiol 65 (2005) 72-84
19. Baumann N., and Pham-Dinh D. Biology of the oligodendrocyte and myelin in the mammalian nervous system. Physiol Rev 81 (2001) 871-927
20. Back S., and Volpe J.J. Cellular and molecular pathogenesis of periventricular white matter injury. Ment Retard Dev Disabil 3 (1997) 96-107
21. National Institute of Neurological Disorders and Stroke web site. Available at http://www.ninds.nih.gov/disorders/cerebral_palsy/cerebral_palsy.htm. Accessed on 3/8/2006.
22. Bakos J., Duncko R., Makatsori A., Pirnik Z., Kiss A., and Jezova D. Prenatal immune challenge affects growth, behavior, and brain dopamine in offspring. Ann NY Acad Sci 1018 (2004) 281-287
23. Hagberg H., Peebles D., and Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 8 (2002) 30-38
24. Eklind S., Mallard C., Arvidsson P., and Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res 58 (2005) 112-116